| A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS: A computational and mechanistic study ZZ Wang, K Li, AR Maskey, W Huang, AA Toutov, N Yang, K Srivastava, ... The FASEB Journal 35 (4), 2021 | 61 | 2021 |
| Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and active compound berberine associated with immunometabolism regulation N Yang, AR Maskey, K Srivastava, M Kim, Z Wang, I Musa, Y Shi, Y Gong, ... Frontiers in Immunology 14, 1081121, 2023 | 6 | 2023 |
| Cytochrome P450 3A4 suppression by epimedium and active compound kaempferol leads to synergistic anti-inflammatory effect with corticosteroid K Li, XH Yu, AR Maskey, I Musa, ZZ Wang, V Garcia, A Guo, N Yang, ... Frontiers in Pharmacology 13, 1042756, 2023 | 5 | 2023 |
| Formononetin isolated from Sophorae flavescentis inhibits B cell-IgE production by regulating ER-stress transcription factor XBP-1 N Yang, I Musa, AR Maskey, K Li, Z Wang, B Liang, S Zhang, J Zhan, ... Frontiers in Allergy 3, 1056203, 2023 | 4 | 2023 |
| Anti‐IgE effect of small‐molecule‐compound arctigenin on food allergy in association with a distinct transcriptome profile M Cao, C Liu, KD Srivastava, A Lin, C Lazarski, L Wang, A Maskey, ... Clinical & Experimental Allergy 52 (2), 250-264, 2022 | 4 | 2022 |
| Induction of severe eosinophilic esophagitis and multi-organ inflammation by airborne allergens is associated with IL-4/IL-13 and CCL11 but not IgE in genetic susceptible mice A Maskey, K Srivastava, G Soffer, D Dunkin, Q Yuan, XM Li Journal of Inflammation Research, 5527-5540, 2022 | 3 | 2022 |
| Computational analysis to define efficacy & molecular mechanisms of 7, 4’- Dihydroxyflavone on eosinophilic esophagitis: Ex-vivo validation in human esophagus … AR Maskey, ZZ Wang, X Chen, D Dunkin, N Yang, G Soffer, Q Yuan, ... Frontiers in Immunology 13, 1015437, 2022 | 2 | 2022 |
| Analysis of biological potency and chemical consistency of ethyl acetate purified FAHF-2 for treatment of food allergy A Maskey, K Srivastava, M Kim, N Yang Journal of Allergy and Clinical Immunology 145 (2), AB141, 2020 | 2 | 2020 |
| A Flavonoid Compound 7, 4 Dihydroxy Flavone as a Potential Therapeutic for the Treatment and Management of EoE AR Maskey, ZZ Wang, X Chen, D Dunkin, G Soffer, Q Yuan, XMR Li The FASEB Journal 36, 2022 | 1 | 2022 |
| The Efficacy & Molecular Mechanisms of a Terpenoid Compound Ganoderic Acid C1 on Corticosteroid-Resistant Neutrophilic Airway Inflammation: In vivo and in vitro Validation ZZ Wang, H Li, AR Maskey, K Srivastava, C Liu, N Yang, T Xie, Z Fu, J Li, ... Journal of Inflammation Research, 2547-2561, 2024 | | 2024 |
| Cannabinoid derived product is a potential novel therapeutic for papillary thyroid carcinoma C Taico, I Musa, F Ardalani, A Maskey, N Yang, J Breslin, R Tiwari, ... Cancer Research 84 (6_Supplement), 5982-5982, 2024 | | 2024 |
| Abstract 2345 Inhibition of Cervical Cancer Cell Function by Cannabinoid-Containing Product, BRF1A is Associated with Regulation of Tumor Suppressor Gene N Krishnan, F Ardalani, A Maskey, I Musa, N Yang, J Breslin, O Paulden, ... Journal of Biological Chemistry 300 (3), 2024 | | 2024 |
| Abstract 1833 Berberine Inhibits Tonsil B Cell IgE Production Following IL-4/Anti-CD40 Stimulation Z Chen, A Maskey, S Hemmerdinger, N Yang, M Spears, D Garber, ... Journal of Biological Chemistry 300 (3), 2024 | | 2024 |
| Sustained silencing peanut allergy by xanthopurpurin is associated with suppression of peripheral and bone marrow IgE-producing B cell N Yang, K Srivastava, Y Chen, H Li, A Maskey, P Yoo, X Liu, RK Tiwari, ... Frontiers in Immunology 15, 1299484, 2024 | | 2024 |
| Investigation of Berberine's Potential in Attenuating Staphylococcus aureus-Induced Inflammatory Responses M Kwan, A Maskey, I Musa, N Yang, XM Li Journal of Allergy and Clinical Immunology 153 (2), AB70, 2024 | | 2024 |
| Inhibition of IgE production in Plasma Cell Line by Cannabinoid-Containing Product Associated with Regulation of XBP-1 and IgE heavy chain expression I Musa, A Maskey, N Yang, J Breslin, XM Li Journal of Allergy and Clinical Immunology 153 (2), AB63, 2024 | | 2024 |
| Inhibition of Staphylococcus aureus induced mast cells/basophils activation via regulation of NFkB signaling pathway by small molecule compound berberine. A Maskey, N Reyes, I Musa, XM Li Journal of Allergy and Clinical Immunology 153 (2), AB227, 2024 | | 2024 |
| Inhibition of Pathologic Immunoglobulin E In Food Allergy by EBF2 and Active Compound Berberine Associated with Immunometabolism Regulation A Maskey, N Yang, M Kim, K Srivastava, Z Wang, Y Shi, Y Gong, J Wang, ... Journal of Allergy and Clinical Immunology 151 (2), AB228, 2023 | | 2023 |
| Traditional Chinese Medicine's Luffa Formula Reduces Nasal and Ocular Symptoms in Patients with Environmental and Food Allergies Z Chen, T McKnight, N Yang, A Maskey, I Musa, XM Li Journal of Allergy and Clinical Immunology 151 (2), AB105, 2023 | | 2023 |
| Small molecule compounds, active ingredients of TCM, as novel therapeutics for eosinophilic esophagitis A Maskey | | 2023 |
Xiu-Min LiIcahn School of Medicine at Mount Sinai在 mssm.edu 的电子邮件经过验证
